A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 08 Feb 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Jun 2023 Results (n=139) assessing the safety and efficacy of ApTOLL in combination with endovascular treatment (EVT) for patients with ischemic stroke, published in the JAMA Neurology.
10 Feb 2023 Results assessing to assess safety and efficacy of ApTOLL combined with endovascular treatment (EVT) in ischemic stroke, presented at the International Stroke Conference 2023.
19 Oct 2022 Status changed from active, no longer recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com